Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 11.2.2 Blood coagulation factors |
This medicine has the best evidence for effectiveness and safety. |
| Chile. Formulario Nacional de Medicamentos. 2005 | 10. PRODUCTOS SANGUINEOS Y SUCEDANEOS DEL PLASMA | No observations |
| List | Section | Observation |
|---|---|---|
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.11 Antifibrinolytic Drugs and Haemostatics | No observations |
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 01.04 HAEMOSTATICS |
Others observations: fraction |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 08.02. FACTORES DE LA COAGULACION | No observations |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Blood Hemostatics |
Others observations: inhibitor bypassing fraction |
| Guyana. Essential Medicines List. 2020-2021 | 12.04. Anti-Fibrinolytic | No observations |
| List | Section | Observation |
|---|---|---|
| Chile. Formulario Nacional de Medicamentos. 2005 | 10. PRODUCTOS SANGUINEOS Y SUCEDANEOS DEL PLASMA | No observations |
| List | Section | Observation |
|---|---|---|
| Chile. Formulario Nacional de Medicamentos. 2005 | 10. PRODUCTOS SANGUINEOS Y SUCEDANEOS DEL PLASMA | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 10. HEMATOLOGIA | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 10. HEMATOLOGIA | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 10. HEMATOLOGIA | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 10. HEMATOLOGIA | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | B. SANGUE E ÓRGÃOS HEMATOPOÉTICOS | No observations |
| El Salvador - 2019 | ANTIHEMORRÁGICOS | No observations |
| Suriname. NGK-C-011 | 11.2 Plasma fractions for specific use | No observations |
| Suriname. NGK-C-011 | 29.2 Other Special Essential Medicines | No observations |
| Haiti. National List of Essential Medicines | 11.02.02 Coagulation factors | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 10. HEMATOLOGIA | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 10. HEMATOLOGIA | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | B. SANGUE E ÓRGÃOS HEMATOPOÉTICOS | No observations |
| Bahamas. Drug Formulary | 11. BLOOD PRODUCTS AND DRUGS AFFECTING THE BLOOD | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 10. HEMATOLOGIA | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | B. SANGUE E ÓRGÃOS HEMATOPOÉTICOS | No observations |